$XRAY
DENTSPLY SIRONA Inc.

2013 Q2 Form 10-Q Financial Statement

#000081847913000028 Filed on August 01, 2013

View on sec.gov

Income Statement

Concept 2013 Q2 2012 Q2
Revenue $761.0M $763.0M
YoY Change -0.26% 25.2%
Cost Of Revenue $346.1M $355.5M
YoY Change -2.66% 20.68%
Gross Profit $415.0M $407.5M
YoY Change 1.84% 29.42%
Gross Profit Margin 54.53% 53.4%
Selling, General & Admin $289.9M $296.0M
YoY Change -2.06% 40.31%
% of Gross Profit 69.87% 72.65%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $32.80M $32.80M
YoY Change 0.0% 68.21%
% of Gross Profit 7.9% 8.05%
Operating Expenses $289.9M $296.0M
YoY Change -2.06% 40.31%
Operating Profit $122.9M $108.9M
YoY Change 12.82% 12.27%
Interest Expense $11.51M $14.32M
YoY Change -19.66% 157.15%
% of Operating Profit 9.37% 13.15%
Other Income/Expense, Net -$4.223M -$982.0K
YoY Change 330.04% -31.52%
Pretax Income $109.4M $95.59M
YoY Change 14.43% 3.41%
Income Tax $22.87M $14.88M
% Of Pretax Income 20.91% 15.56%
Net Earnings $87.23M $80.76M
YoY Change 8.0% 8.79%
Net Earnings / Revenue 11.46% 10.59%
Basic Earnings Per Share $0.61 $0.57
Diluted Earnings Per Share $0.60 $0.56
COMMON SHARES
Basic Shares Outstanding 142.9M shares 141.7M shares
Diluted Shares Outstanding 145.1M shares 143.9M shares

Balance Sheet

Concept 2013 Q2 2012 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $57.00M $53.00M
YoY Change 7.55% -92.11%
Cash & Equivalents $57.03M $53.21M
Short-Term Investments
Other Short-Term Assets $181.0M $187.0M
YoY Change -3.21% 34.53%
Inventory $433.2M $403.2M
Prepaid Expenses
Receivables $499.0M $462.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.170B $1.105B
YoY Change 5.87% -28.79%
LONG-TERM ASSETS
Property, Plant & Equipment $605.0M $587.3M
YoY Change 3.02% 32.57%
Goodwill $2.159B $2.036B
YoY Change 6.01%
Intangibles $786.7M $947.7M
YoY Change -17.0%
Long-Term Investments $2.000M
YoY Change
Other Assets $154.4M $194.5M
YoY Change -20.59% 6.26%
Total Long-Term Assets $3.705B $3.766B
YoY Change -1.62% 78.89%
TOTAL ASSETS
Total Short-Term Assets $1.170B $1.105B
Total Long-Term Assets $3.705B $3.766B
Total Assets $4.875B $4.871B
YoY Change 0.08% 33.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $147.5M $145.9M
YoY Change 1.1% 27.94%
Accrued Expenses $308.1M $347.9M
YoY Change -11.43% 22.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $417.0M $242.0M
YoY Change 72.31% 2588.89%
Total Short-Term Liabilities $890.6M $748.2M
YoY Change 19.03% 74.0%
LONG-TERM LIABILITIES
Long-Term Debt $1.124B $1.483B
YoY Change -24.21% 126.38%
Other Long-Term Liabilities $353.6M $316.1M
YoY Change 11.85% -22.71%
Total Long-Term Liabilities $1.477B $1.799B
YoY Change -17.87% 69.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $890.6M $748.2M
Total Long-Term Liabilities $1.477B $1.799B
Total Liabilities $2.587B $2.882B
YoY Change -10.24% 78.55%
SHAREHOLDERS EQUITY
Retained Earnings $2.959B $2.654B
YoY Change 11.5%
Common Stock $1.628M $1.628M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $732.2M $731.3M
YoY Change 0.13%
Treasury Stock Shares 20.60M shares 21.00M shares
Shareholders Equity $2.250B $1.952B
YoY Change
Total Liabilities & Shareholders Equity $4.875B $4.871B
YoY Change 0.08% 33.19%

Cashflow Statement

Concept 2013 Q2 2012 Q2
OPERATING ACTIVITIES
Net Income $87.23M $80.76M
YoY Change 8.0% 8.79%
Depreciation, Depletion And Amortization $32.80M $32.80M
YoY Change 0.0% 68.21%
Cash From Operating Activities $95.80M $83.40M
YoY Change 14.87% -31.53%
INVESTING ACTIVITIES
Capital Expenditures -$22.90M -$24.40M
YoY Change -6.15% 78.1%
Acquisitions
YoY Change
Other Investing Activities -$40.60M -$13.90M
YoY Change 192.09% -3.47%
Cash From Investing Activities -$63.50M -$38.30M
YoY Change 65.8% 36.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -29.00M -55.00M
YoY Change -47.27% 179.19%
NET CHANGE
Cash From Operating Activities 95.80M 83.40M
Cash From Investing Activities -63.50M -38.30M
Cash From Financing Activities -29.00M -55.00M
Net Change In Cash 3.300M -9.900M
YoY Change -133.33% -113.36%
FREE CASH FLOW
Cash From Operating Activities $95.80M $83.40M
Capital Expenditures -$22.90M -$24.40M
Free Cash Flow $118.7M $107.8M
YoY Change 10.11% -20.44%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q4 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
442412000 USD
CY2013Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
499006000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
165290000 USD
CY2013Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
147455000 USD
CY2013Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
17947000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
39191000 USD
CY2012Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
424336000 USD
CY2013Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
308148000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-144200000 USD
CY2013Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-223222000 USD
CY2011Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-190970000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-203712000 USD
CY2013Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
244598000 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
246548000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
28014000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
23434000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1122000 USD
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
5163000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12023000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11029000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6392000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10319000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10565000 USD
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6213000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2592000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2391000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3500000 shares
CY2013Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2900000 shares
CY2012Q4 us-gaap Assets
Assets
4972297000 USD
CY2013Q2 us-gaap Assets
Assets
4874683000 USD
CY2013Q2 us-gaap Assets Current
AssetsCurrent
1170033000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
1111096000 USD
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
97668000 USD
CY2013Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
96542000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80132000 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57027000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
53210000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
77128000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23105000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-23918000 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.11
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
2400000 USD
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2013Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2013Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162800000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
162800000 shares
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1628000 USD
CY2013Q2 us-gaap Common Stock Value
CommonStockValue
1628000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
79891000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
63107000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
121307000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-54917000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-928000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1356000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2200000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
2019000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
82091000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-55845000 USD
CY2013Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
65126000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
122663000 USD
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Additional Interest Issued To Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesAdditionalInterestIssuedToParent
5000000 USD
us-gaap Consolidation Less Than Wholly Owned Subsidiary Parent Ownership Interest Changes Purchase Of Interest By Parent
ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent
9000000 USD
CY2013Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
346054000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
679188000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
689938000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
355525000 USD
CY2013Q2 us-gaap Debt Current
DebtCurrent
417065000 USD
CY2012Q4 us-gaap Debt Current
DebtCurrent
298963000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4432000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8564000 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
232641000 USD
CY2013Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
218624000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
CY2012Q2 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Curtailments
DefinedBenefitPlanRecognizedNetGainLossDueToCurtailments
0 USD
us-gaap Depreciation
Depreciation
40357000 USD
us-gaap Depreciation
Depreciation
41743000 USD
CY2012Q4 us-gaap Derivative Assets
DerivativeAssets
22525000 USD
CY2013Q2 us-gaap Derivative Assets
DerivativeAssets
34985000 USD
CY2013Q2 us-gaap Derivative Assets Liabilities At Fair Value Net
DerivativeAssetsLiabilitiesAtFairValueNet
-11130000 USD
CY2012Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2013Q2 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
5427000 USD
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral
11209000 USD
CY2012Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
184346000 USD
CY2013Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
85516000 USD
CY2013Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
2615000 USD
CY2012Q2 us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
449000 USD
us-gaap Derivative Instruments Gain Loss Recognized In Income Net
DerivativeInstrumentsGainLossRecognizedInIncomeNet
15000 USD
CY2012Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-33156000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
1741000 USD
CY2013Q2 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
24681000 USD
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
-12075000 USD
CY2012Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
201444000 USD
CY2013Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
109292000 USD
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2013, the FASB issued ASU No. 2013-05, &#8220;Foreign Currency Matters (Topic 830): Parent&#8217;s Accounting for the Cumulative Translation Adjustment upon Derecognition of Certain Subsidiaries or Groups of Assets within a Foreign Entity or of an Investment in a Foreign Entity.&#8221; This newly issued accounting standard requires a cumulative translation adjustment (&#8220;CTA&#8221;)attached to the parent&#8217;s investment in a foreign entity should be released in a manner consistent with the derecognition guidance on investment entities. Thus the entire amount of CTA associated with the foreign entity would be released when there has been a sale of a subsidiary or group of net assets within a foreign entity and the sale represents a complete liquidation of the investment in the foreign entity, a loss of a controlling financial interest in an investment in a foreign entity, or step acquisition for a foreign entity. The adoption of this standard will not materially impact the Company&#8217;s financial position or results of operations. The Company expects to adopt this accounting standard for the quarter ending March 31, 2014.</font></div></div>
us-gaap Dividends Cash
DividendsCash
17832000 USD
us-gaap Dividends Cash
DividendsCash
15599000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2013Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.57
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.93
CY2013Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.10
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3349000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1392000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2935000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
2865000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1916000 USD
CY2013Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1788000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
-4657000 USD
us-gaap Employee Stock Ownership Plan Esop Cash Contributions To Esop
EmployeeStockOwnershipPlanESOPCashContributionsToESOP
-3642000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1122000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5163000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
5163000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1122000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
184117000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
204791000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
768555000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
785139000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
601022000 USD
CY2013Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
563764000 USD
CY2013Q2 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
5000000 USD
CY2013Q2 us-gaap Goodwill
Goodwill
2158529000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
2210953000 USD
us-gaap Goodwill Other Changes
GoodwillOtherChanges
0 USD
us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
-52424000 USD
CY2013Q2 us-gaap Gross Profit
GrossProfit
414956000 USD
us-gaap Gross Profit
GrossProfit
800219000 USD
us-gaap Gross Profit
GrossProfit
803156000 USD
CY2012Q2 us-gaap Gross Profit
GrossProfit
407469000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
95586000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
168778000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
187273000 USD
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
109379000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2919000 USD
CY2012Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1329000 USD
CY2013Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2182000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
403000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26412000 USD
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14875000 USD
CY2013Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22870000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29590000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
72324000 USD
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
41461000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11143000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1320000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-17670000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5423000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3621000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3244000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
47034000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
40700000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
3596000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
6100000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26364000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19455000 USD
CY2013Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2211000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2179000 shares
CY2012Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2126000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2258000 shares
CY2013Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
786667000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
830642000 USD
us-gaap Interest Expense
InterestExpense
30105000 USD
us-gaap Interest Expense
InterestExpense
26728000 USD
CY2012Q2 us-gaap Interest Expense
InterestExpense
14323000 USD
CY2013Q2 us-gaap Interest Expense
InterestExpense
11507000 USD
CY2013Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
263590000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
248870000 USD
CY2012Q4 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
5900000 USD
CY2013Q2 us-gaap Inventory Lifo Reserve
InventoryLIFOReserve
6000000 USD
CY2013Q2 us-gaap Inventory Net
InventoryNet
433189000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
402940000 USD
CY2013Q2 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
93580000 USD
CY2012Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
81537000 USD
CY2013Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
33900000 USD
CY2012Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
32600000 USD
CY2013Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
76019000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
72533000 USD
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
2243000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1984000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
3862000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
4418000 USD
CY2013Q2 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
7200000 USD
CY2012Q4 us-gaap Lifo Inventory Amount
LIFOInventoryAmount
6300000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2722854000 USD
CY2013Q2 us-gaap Liabilities
Liabilities
2586587000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4972297000 USD
CY2013Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4874683000 USD
CY2013Q2 us-gaap Liabilities Current
LiabilitiesCurrent
890615000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
927780000 USD
CY2012Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
356004000 USD
CY2013Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
262505000 USD
CY2013Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1123792000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1222035000 USD
us-gaap Maximum Length Of Time Hedged In Interest Rate Cash Flow Hedge1
MaximumLengthOfTimeHedgedInInterestRateCashFlowHedge1
P18M
CY2012Q4 us-gaap Minority Interest
MinorityInterest
40745000 USD
CY2013Q2 us-gaap Minority Interest
MinorityInterest
37911000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-67414000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15436000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-136188000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58507000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
131868000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
103395000 USD
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
87228000 USD
us-gaap Net Income Loss
NetIncomeLoss
158913000 USD
us-gaap Net Income Loss
NetIncomeLoss
134049000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
80764000 USD
CY2013Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1463000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2351000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2220000 USD
CY2012Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1276000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2080000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
995000 USD
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1013000 USD
CY2012Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
825000 USD
us-gaap Noncontrolling Interest Increase From Business Combination
NoncontrollingInterestIncreaseFromBusinessCombination
-8960000 USD
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
122866000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
196066000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
108907000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
216724000 USD
CY2013Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
154426000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
204901000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-8989000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-7954000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-16629000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
15046000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-45275000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
5886000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-178746000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-88256000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-13606000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-23565000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-79173000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-137885000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-12742000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-79022000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1666000 USD
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
3316000 USD
CY2013Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
540000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1726000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-14756000 USD
CY2013Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
13362000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-47089000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-14957000 USD
CY2013Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
353556000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
340398000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
11480000 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
-3102000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-982000 USD
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4223000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7141000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1045000 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
1135000 USD
us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
80000 USD
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
14221000 USD
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
94843000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
62278000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
38840000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
15706000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
16928000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3939000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
188000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
963000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
1577000 USD
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
0 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
46151000 USD
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
42986000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000.00 shares
CY2013Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
250000.00 shares
CY2013Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
185612000 USD
CY2013Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
180811000 USD
us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
25000 USD
us-gaap Proceeds From Hedge Financing Activities
ProceedsFromHedgeFinancingActivities
0 USD
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
0 USD
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
7499000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-35181000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
40450000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2209000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
465000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31213000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20066000 USD
us-gaap Profit Loss
ProfitLoss
161264000 USD
CY2013Q2 us-gaap Profit Loss
ProfitLoss
88691000 USD
CY2012Q2 us-gaap Profit Loss
ProfitLoss
82040000 USD
us-gaap Profit Loss
ProfitLoss
136269000 USD
CY2013Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
605028000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
614705000 USD
CY2012Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
3094000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
5560000 USD
CY2013Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
3337000 USD
us-gaap Restricted Stock Expense
RestrictedStockExpense
4640000 USD
CY2013Q2 us-gaap Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
2100000 USD
us-gaap Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
3500000 USD
us-gaap Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
2800000 USD
CY2012Q2 us-gaap Restructuring And Related Cost Expected Cost
RestructuringAndRelatedCostExpectedCost
2100000 USD
us-gaap Restructuring Charges
RestructuringCharges
3749000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
1570000 USD
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2105000 USD
CY2013Q2 us-gaap Restructuring Reserve
RestructuringReserve
10511000 USD
CY2012Q4 us-gaap Restructuring Reserve
RestructuringReserve
14475000 USD
us-gaap Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
780000 USD
us-gaap Restructuring Reserve Settled With Cash
RestructuringReserveSettledWithCash
6933000 USD
CY2013Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2169000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
3765000 USD
CY2012Q2 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2528000 USD
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
2834000 USD
CY2013Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2959391000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2818461000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1479407000 USD
CY2013Q2 us-gaap Sales Revenue Net
SalesRevenueNet
761010000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
1493094000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
762994000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
296034000 USD
CY2013Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
289921000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
583598000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
600388000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12023000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11029000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
120000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
38.75
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
499000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
40.89
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1034000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
1177000 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
38.78
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
36.34
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
236000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
32.57
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3383000 USD
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-3276000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31213000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20066000 USD
CY2012Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3298000 USD
CY2013Q2 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2876000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5005000 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
5679000 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
2250185000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
2208698000 USD
CY2013Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2288096000 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2249443000 USD
CY2012Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1988999000 USD
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1884151000 USD
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
20500000 shares
CY2013Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
20600000 shares
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
713739000 USD
CY2013Q2 us-gaap Treasury Stock Value
TreasuryStockValue
732210000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
62278000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
38840000 USD
CY2013Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145133000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143908000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
145107000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
143863000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142849000 shares
CY2013Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142922000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141729000 shares
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
141737000 shares
CY2012Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
142922000 shares
CY2012Q4 xray Accumulated Other Comprehensive Income Loss Foreign Currency Translation Losses Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationLossesNetOfTax
-123400000 USD
CY2013Q2 xray Accumulated Other Comprehensive Income Loss Foreign Currency Translation Losses Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationLossesNetOfTax
-110900000 USD
CY2012Q4 xray Accumulatedothercomprehensiveincomelossforeigncurrencytranslationgainsnetoftax
Accumulatedothercomprehensiveincomelossforeigncurrencytranslationgainsnetoftax
177700000 USD
CY2013Q2 xray Accumulatedothercomprehensiveincomelossforeigncurrencytranslationgainsnetoftax
Accumulatedothercomprehensiveincomelossforeigncurrencytranslationgainsnetoftax
77100000 USD
CY2012Q2 xray Antidilutive Securities Excluded From Computation Of Earnings Per Share
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare
3800000 shares
xray Antidilutive Securities Excluded From Computation Of Earnings Per Share
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShare
4100000 shares
xray Cash Paid For Contingent Consideration
CashPaidForContingentConsideration
1781000 USD
xray Cash Paid For Contingent Consideration
CashPaidForContingentConsideration
0 USD
CY2012Q4 xray Derivative Asset Not Subject To Master Netting Arrangement
DerivativeAssetNotSubjectToMasterNettingArrangement
22525000 USD
CY2013Q2 xray Derivative Asset Not Subject To Master Netting Arrangement
DerivativeAssetNotSubjectToMasterNettingArrangement
34985000 USD
CY2012Q4 xray Derivative Asset Securities Purchasedunder Agreementsto Resell Securities Borrowed Collateral Obligationto Return Securities
DerivativeAssetSecuritiesPurchasedunderAgreementstoResellSecuritiesBorrowedCollateralObligationtoReturnSecurities
17098000 USD
CY2013Q2 xray Derivative Asset Securities Purchasedunder Agreementsto Resell Securities Borrowed Collateral Obligationto Return Securities
DerivativeAssetSecuritiesPurchasedunderAgreementstoResellSecuritiesBorrowedCollateralObligationtoReturnSecurities
23776000 USD
CY2013Q2 xray Derivative Instruments Gain Loss Included In Accumulated Other Comprehensive Loss Income
DerivativeInstrumentsGainLossIncludedInAccumulatedOtherComprehensiveLossIncome
-13735000 USD
CY2012Q2 xray Derivative Instruments Gain Loss Included In Accumulated Other Comprehensive Loss Income
DerivativeInstrumentsGainLossIncludedInAccumulatedOtherComprehensiveLossIncome
73784000 USD
xray Derivative Instruments Gain Loss Included In Accumulated Other Comprehensive Loss Income
DerivativeInstrumentsGainLossIncludedInAccumulatedOtherComprehensiveLossIncome
23415000 USD
xray Derivative Instruments Gain Loss Included In Accumulated Other Comprehensive Loss Income
DerivativeInstrumentsGainLossIncludedInAccumulatedOtherComprehensiveLossIncome
26150000 USD
CY2012Q4 xray Derivative Liability Not Subject To Master Netting Arrangement
DerivativeLiabilityNotSubjectToMasterNettingArrangement
201444000 USD
CY2013Q2 xray Derivative Liability Not Subject To Master Netting Arrangement
DerivativeLiabilityNotSubjectToMasterNettingArrangement
109292000 USD
CY2012Q4 xray Derivative Liability Securities Soldunder Agreementsto Resell Securities Loaned Collateral Rightto Reclaim Securities
DerivativeLiabilitySecuritiesSoldunderAgreementstoResellSecuritiesLoanedCollateralRighttoReclaimSecurities
-17098000 USD
CY2013Q2 xray Derivative Liability Securities Soldunder Agreementsto Resell Securities Loaned Collateral Rightto Reclaim Securities
DerivativeLiabilitySecuritiesSoldunderAgreementstoResellSecuritiesLoanedCollateralRighttoReclaimSecurities
-23776000 USD
CY2013Q2 xray Discount Rate Used In Goodwill Impairment Testing Lower Limit
DiscountRateUsedInGoodwillImpairmentTestingLowerLimit
0.084
CY2013Q2 xray Discount Rate Used In Goodwill Impairment Testing Upper Limit
DiscountRateUsedInGoodwillImpairmentTestingUpperLimit
0.115
CY2012Q4 xray Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
1014759000 USD
CY2013Q2 xray Identifiable Intangible Assets Gross
IdentifiableIntangibleAssetsGross
991458000 USD
xray Increase Decrease Other Noncurrent Assets
IncreaseDecreaseOtherNoncurrentAssets
-845000 USD
xray Increase Decrease Other Noncurrent Assets
IncreaseDecreaseOtherNoncurrentAssets
3497000 USD
xray Intersegment Eliminations
IntersegmentEliminations
294085000 USD
xray Intersegment Eliminations
IntersegmentEliminations
294883000 USD
CY2012Q2 xray Intersegment Eliminations
IntersegmentEliminations
152821000 USD
CY2013Q2 xray Intersegment Eliminations
IntersegmentEliminations
148682000 USD
CY2012Q2 xray Net Sales Excluding Precious Metal Content
NetSalesExcludingPreciousMetalContent
698480000 USD
xray Net Sales Excluding Precious Metal Content
NetSalesExcludingPreciousMetalContent
1364106000 USD
xray Net Sales Excluding Precious Metal Content
NetSalesExcludingPreciousMetalContent
1388605000 USD
CY2013Q2 xray Net Sales Excluding Precious Metal Content
NetSalesExcludingPreciousMetalContent
715955000 USD
xray Number Of Groups Of Significant Interest Rate Swaps
NumberOfGroupsOfSignificantInterestRateSwaps
2 group
CY2013Q2 xray Number Of Reporting Units
NumberOfReportingUnits
13
xray Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-11747000 USD
xray Other Comprehensive Income Loss Before Reclassification Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationNetOfTax
-81102000 USD
xray Payments To Noncontrolling Interest Net Of Cash Acquired
PaymentsToNoncontrollingInterestNetOfCashAcquired
8960000 USD
xray Payments To Noncontrolling Interest Net Of Cash Acquired
PaymentsToNoncontrollingInterestNetOfCashAcquired
0 USD
CY2013Q2 xray Precious Metal Content
PreciousMetalContent
45055000 USD
CY2012Q2 xray Precious Metal Content
PreciousMetalContent
64514000 USD
xray Precious Metal Content
PreciousMetalContent
104489000 USD
xray Precious Metal Content
PreciousMetalContent
115301000 USD
xray Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-995000 USD
xray Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
2080000 USD
xray Segment Reporting Information Inter Segment Revenue Net Of Eliminations
SegmentReportingInformationInterSegmentRevenueNetOfEliminations
0 USD
CY2013Q2 xray Segment Reporting Information Inter Segment Revenue Net Of Eliminations
SegmentReportingInformationInterSegmentRevenueNetOfEliminations
0 USD
CY2012Q2 xray Segment Reporting Information Inter Segment Revenue Net Of Eliminations
SegmentReportingInformationInterSegmentRevenueNetOfEliminations
0 USD
xray Segment Reporting Information Inter Segment Revenue Net Of Eliminations
SegmentReportingInformationInterSegmentRevenueNetOfEliminations
0 USD
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
dei Document Period End Date
DocumentPeriodEndDate
2013-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000818479
CY2013Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
142288292 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
DENTSPLY INTERNATIONAL INC /DE/
dei Trading Symbol
TradingSymbol
XRAY

Files In Submission

Name View Source Status
0000818479-13-000028-index-headers.html Edgar Link pending
0000818479-13-000028-index.html Edgar Link pending
0000818479-13-000028.txt Edgar Link pending
0000818479-13-000028-xbrl.zip Edgar Link pending
dentsply10-q2.htm Edgar Link pending
exhibit311111.htm Edgar Link pending
exhibit31amendedandrestate.htm Edgar Link pending
exhibit321111.htm Edgar Link pending
exhibit32amendedandrestate.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R1.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R10.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R11.xml Edgar Link unprocessable
R12.htm Edgar Link pending
R12.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R13.xml Edgar Link unprocessable
R14.htm Edgar Link pending
R14.xml Edgar Link unprocessable
R15.htm Edgar Link pending
R15.xml Edgar Link unprocessable
R16.htm Edgar Link pending
R16.xml Edgar Link unprocessable
R17.htm Edgar Link pending
R17.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R18.xml Edgar Link unprocessable
R19.htm Edgar Link pending
R19.xml Edgar Link unprocessable
R2.htm Edgar Link pending
R2.xml Edgar Link unprocessable
R20.htm Edgar Link pending
R20.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R21.xml Edgar Link unprocessable
R22.htm Edgar Link pending
R22.xml Edgar Link unprocessable
R23.htm Edgar Link pending
R23.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R24.xml Edgar Link unprocessable
R25.htm Edgar Link pending
R25.xml Edgar Link unprocessable
R26.htm Edgar Link pending
R26.xml Edgar Link unprocessable
R27.htm Edgar Link pending
R27.xml Edgar Link unprocessable
R28.htm Edgar Link pending
R28.xml Edgar Link unprocessable
R29.htm Edgar Link pending
R29.xml Edgar Link unprocessable
R3.htm Edgar Link pending
R3.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R30.xml Edgar Link unprocessable
R31.htm Edgar Link pending
R31.xml Edgar Link unprocessable
R32.htm Edgar Link pending
R32.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R33.xml Edgar Link unprocessable
R34.htm Edgar Link pending
R34.xml Edgar Link unprocessable
R35.htm Edgar Link pending
R35.xml Edgar Link unprocessable
R36.htm Edgar Link pending
R36.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R37.xml Edgar Link unprocessable
R38.htm Edgar Link pending
R38.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R39.xml Edgar Link unprocessable
R4.htm Edgar Link pending
R4.xml Edgar Link unprocessable
R40.htm Edgar Link pending
R40.xml Edgar Link unprocessable
R41.htm Edgar Link pending
R41.xml Edgar Link unprocessable
R42.htm Edgar Link pending
R42.xml Edgar Link unprocessable
R43.htm Edgar Link pending
R43.xml Edgar Link unprocessable
R44.htm Edgar Link pending
R44.xml Edgar Link unprocessable
R45.htm Edgar Link pending
R45.xml Edgar Link unprocessable
R46.htm Edgar Link pending
R46.xml Edgar Link unprocessable
R47.htm Edgar Link pending
R47.xml Edgar Link unprocessable
R48.htm Edgar Link pending
R48.xml Edgar Link unprocessable
R49.htm Edgar Link pending
R49.xml Edgar Link unprocessable
R5.htm Edgar Link pending
R5.xml Edgar Link unprocessable
R50.htm Edgar Link pending
R50.xml Edgar Link unprocessable
R51.htm Edgar Link pending
R51.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R52.xml Edgar Link unprocessable
R53.htm Edgar Link pending
R53.xml Edgar Link unprocessable
R54.htm Edgar Link pending
R54.xml Edgar Link unprocessable
R55.htm Edgar Link pending
R55.xml Edgar Link unprocessable
R56.htm Edgar Link pending
R56.xml Edgar Link unprocessable
R57.htm Edgar Link pending
R57.xml Edgar Link unprocessable
R58.htm Edgar Link pending
R58.xml Edgar Link unprocessable
R59.htm Edgar Link pending
R59.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R6.xml Edgar Link unprocessable
R60.htm Edgar Link pending
R60.xml Edgar Link unprocessable
R61.htm Edgar Link pending
R61.xml Edgar Link unprocessable
R62.htm Edgar Link pending
R62.xml Edgar Link unprocessable
R63.htm Edgar Link pending
R63.xml Edgar Link unprocessable
R64.htm Edgar Link pending
R64.xml Edgar Link unprocessable
R65.htm Edgar Link pending
R65.xml Edgar Link unprocessable
R66.htm Edgar Link pending
R66.xml Edgar Link unprocessable
R67.htm Edgar Link pending
R67.xml Edgar Link unprocessable
R68.htm Edgar Link pending
R68.xml Edgar Link unprocessable
R69.htm Edgar Link pending
R69.xml Edgar Link unprocessable
R7.htm Edgar Link pending
R7.xml Edgar Link unprocessable
R70.htm Edgar Link pending
R70.xml Edgar Link unprocessable
R71.htm Edgar Link pending
R71.xml Edgar Link unprocessable
R72.htm Edgar Link pending
R72.xml Edgar Link unprocessable
R73.htm Edgar Link pending
R73.xml Edgar Link unprocessable
R74.htm Edgar Link pending
R74.xml Edgar Link unprocessable
R8.htm Edgar Link pending
R8.xml Edgar Link unprocessable
R9.htm Edgar Link pending
R9.xml Edgar Link unprocessable
report.css Edgar Link pending
Show.js Edgar Link pending
xray-20130630.xml Edgar Link completed
xray-20130630.xsd Edgar Link pending
xray-20130630_cal.xml Edgar Link unprocessable
xray-20130630_def.xml Edgar Link unprocessable
xray-20130630_lab.xml Edgar Link unprocessable
xray-20130630_pre.xml Edgar Link unprocessable